The history of Leica Biosystems is a history of science and technology innovation. 150+ years we’ve tackled pathology challenges head on, from better slide production to world‑leading Digital Pathology empowering AI development. Our passionate experts drive our mission of Advancing Cancer Diagnostics, Improving Lives.
The BOND-PRIME staining platform delivers high productivity, featuring Universal Access, and can seamlessly adapt to your incoming workflow demands – whether it be batched, continuous, single slide or STAT cases, or a combination of all the above.*
The Aperio GT 450 DX is designed to scale up digital pathology operations by increasing throughput in high volume clinical pathology laboratories. The system uses innovative colour calibration technology to output consistent high-quality images enabling on-time, on-screen diagnosis. Aperio GT450 DX is an automated, high capacity digital pathology slide scanner that offers exceptional image quality, rapid delivery of cases and high-performance streamlined digital viewing built with the pathologist in mind. **
Give every tissue type and size the treatment it deserves. Establish a workflow that meets the demands of your laboratory without compromises on tissue quality. The HistoCore PEGASUS tissue processor enables you to run multiple protocols in parallel on a single instrument, ensuring optimal conditions for all tissue types without slowing down your laboratory.***
Your time matters. Speed up slide processing while maintaining quality and consistency with the HistoCore SPECTRA Workstation, the only workstation that provides consistent staining from slides 1 to 1,600. It also offers the fastest glass coverslipping drying time on the market at only 5 minutes, processing slides that are instantly dry to the touch.****
Fewer resources, more to do, and less time to get work done. While we can’t eliminate these pressures, we can help you make the most of each minute, meet your metrics, and consistently deliver slides on-time.
Whether delivering clinical diagnostics or the next research breakthrough, every moment matters. There is constant pressure to quickly produce reliable results. Meet the challenge with solutions engineered to address today’s needs and tomorrow’s opportunities.
Adopting digital pathology is complex, but it doesn’t have to be complicated. Leica Biosystems can clarify your organization’s path to digitally driven discoveries or diagnostics. Our world-leading, modular technology is supported by experience with thousands of Aperio Digital Pathology implementations worldwide.
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the process. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
If you have an idea, product or technology that you believe could make a step forward in advancing cancer diagnostics, please do not hesitate to reach out.
* For in vitro diagnostic use
** For In Vitro Diagnostic Use.
The clinical use claims described for the products in the information supplied have not been cleared or approved by the U.S. FDA or are not available in the United States.
*** For In-Vitro Diagnostic Use
**** Histocore SPECTRA is a trademark of the Leica Biosystems group of companies in the USA an doptionally in other countries. Other logos, product and/or company names might be trademarks of their respective owners.
